META Pharmaceuticals
A VC-backed early-stage company that is utilizing the power of metabolism to modulate the immune system to treat various diseases, including broad rages of autoimmune diseases and cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$60—90m (Dealroom.co estimates Jun 2022.)
Shenzhen Guangdong (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $15.0m | Seed | |
| Total Funding | $15.0m | ||